Table 3.

The effects of the leaf latex extract of Aloe megalacantha in STZ-induced diabetic mice.

Groups	Blood glucose level in mg/dL
	Day 0	Day 7	Day 14
NC	101.33 ± 4.073a	99.83 ± 3.203a	102.33 ± 3.883a
DC	264.33 ± 5.49	266.83 ± 1.13	268.83 ± 5.05
GL5	256.33 ± 4.63	219.50 ± 4.283a3b	191.67 ± 1.583a3b3c
AM100	265.33 ± 7.67	241.50 ± 6.551a1b	203.83 ± 2.353a2b2c
AM200	262.17 ± 5.29	239.50 ± 7.101a1b	204.00 ± 1.963a3b3c
AM400	265.50 ± 9.86	241.17 ± 6.941a	202.00 ± 1.883a3b2c

Results are expressed in mean ± S.E.M, n = 6; DW10 = distilled water 10 ml/kg; DC = diabetic control; GL5 = glibenclamide 5 mg/kg; AM100 = A. megalacantha extract 100 mg/kg; AM200 = A. megalacantha extract 200 mg/kg; AM400 = A. megalacantha extract 400 mg/kg; ^acompared with diabetic control group, ^bcompared to 0 days, ^ccompared to 7 days, ¹p < 0.05, ²p < 0.01, ³p < 0.001.